GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Sirnaomics Ltd (HKSE:02257) » Definitions » FCF Margin %

Sirnaomics (HKSE:02257) FCF Margin % : -245.39% (As of Dec. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Sirnaomics FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Sirnaomics's Free Cash Flow for the six months ended in Dec. 2024 was HK$-33.92 Mil. Sirnaomics's Revenue for the six months ended in Dec. 2024 was HK$13.82 Mil. Therefore, Sirnaomics's FCF Margin % for the quarter that ended in Dec. 2024 was -245.39%.

As of today, Sirnaomics's current FCF Yield % is -105.18%.

The historical rank and industry rank for Sirnaomics's FCF Margin % or its related term are showing as below:

HKSE:02257' s FCF Margin % Range Over the Past 10 Years
Min: -1116.41   Med: 0   Max: 0
Current: -1116.41

HKSE:02257's FCF Margin % is not ranked
in the Biotechnology industry.
Industry Median: -140.87 vs HKSE:02257: -1116.41

Sirnaomics FCF Margin % Historical Data

The historical data trend for Sirnaomics's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sirnaomics FCF Margin % Chart

Sirnaomics Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
FCF Margin %
Get a 7-Day Free Trial - - - - -1,109.57

Sirnaomics Semi-Annual Data
Dec19 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
FCF Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -245.39

Competitive Comparison of Sirnaomics's FCF Margin %

For the Biotechnology subindustry, Sirnaomics's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Sirnaomics's FCF Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Sirnaomics's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Sirnaomics's FCF Margin % falls into.


;
;

Sirnaomics FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Sirnaomics's FCF Margin for the fiscal year that ended in Dec. 2024 is calculated as

FCF Margin=Free Cash Flow (A: Dec. 2024 )/Revenue (A: Dec. 2024 )
=-153.354/13.821
=-1,109.57 %

Sirnaomics's FCF Margin for the quarter that ended in Dec. 2024 is calculated as

FCF Margin=Free Cash Flow (Q: Dec. 2024 )/Revenue (Q: Dec. 2024 )
=-33.915/13.821
=-245.39 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Sirnaomics FCF Margin % Related Terms

Thank you for viewing the detailed overview of Sirnaomics's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Sirnaomics Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Sirnaomics Ltd (HKSE:02257) » Definitions » FCF Margin %
Comparable Companies
HKSE:00690 HKSE:02185 HKSE:02197 HKSE:06628 HKSE:09939 HKSE:02898 HKSE:08158 HKSE:01228 HKSE:02511 HKSE:01244 VRTX ASX:CSL REGN XKRX:207940 XBRU:ARGX XBRU:UCB ALNY ONC BNTX XKRX:068270
Traded in Other Exchanges
N/A
Address
No.218 Xinghu Street, Unit 415, A4 Building, Suzhou Industrial Park, Suzhou, CHN
Website
https://www.sirnaomics.com
Sirnaomics Ltd is a therapeutics biopharmaceutical company with product candidates in preclinical and clinical stages that focuses on the discovery and development of drugs for indications with medical needs and large market opportunities. The Group's operations and non-current assets are located at the United States of America and the mainland of the People's Republic of China.
Executives
Poon Hung Fai 2101 Beneficial owner
Lu Yang 2101 Beneficial owner
Jpmorgan Chase & Co. 2201 Interest of corporation controlled by you
Dai Xiaochang 2201 Interest of corporation controlled by you
Yan Xia Ling 2202 Interest of your spouse
Ceng Yu 2201 Interest of corporation controlled by you
Li Jie 2201 Interest of corporation controlled by you
Li Lele 2202 Interest of your spouse
Shanghai Chongshi Enterprise Management Partnership(lp) 2101 Beneficial owner
Shenzhen Qianhai Rotating Boulder Fund Management Co.,ltd 2201 Interest of corporation controlled by you
Shenzhen Rotating Boulder Tiancheng The Second Investment Partnership (limited Partnership) 2201 Interest of corporation controlled by you
Shenzhen Rotating Boulder Tiancheng The Third Investment Partnership (limited Partnership) 2201 Interest of corporation controlled by you

Sirnaomics Headlines

No Headlines